PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
9.68M
The estimated revenue has increased from the previous period.
-1.93M
The estimated EBITDA has decreased from the previous period.
-1.38
The estimated EPS has increased from the previous period.
-41.62M
The estimated net income has decreased from the previous period.
-1.93M
The estimated EBIT has decreased from the previous period.
358.54M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-21.77M
No previous data to compare.
100.00%
No previous data to compare.
-22.21M
No previous data to compare.
100.00%
No previous data to compare.
447.00K
No previous data to compare.
63.56M
No previous data to compare.
100.00%
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
100.00%
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
100.00%
No previous data to compare.
4.34M
No previous data to compare.
100.00%
No previous data to compare.
-253.00K
No previous data to compare.
100.00%
No previous data to compare.
4.99%
No previous data to compare.
5.02%
No previous data to compare.
4.08%
No previous data to compare.
-0.23
No previous data to compare.
30.07M
No previous data to compare.
1.57M
No previous data to compare.
49.31M
No previous data to compare.
50.89M
No previous data to compare.
3.09%
No previous data to compare.
96.91%
No previous data to compare.
-22.04M
No previous data to compare.
-17.50M
No previous data to compare.
2.00%
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
No previous data to compare.
71.33M
No previous data to compare.
2.37
No previous data to compare.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.